Last reviewed · How we verify
7-valent pneumococcal-OMPC conjugate vaccine — Competitive Intelligence Brief
phase 3
Biologic
Live · refreshed every 30 min
Target snapshot
7-valent pneumococcal-OMPC conjugate vaccine (7-valent pneumococcal-OMPC conjugate vaccine) — Finnish Institute for Health and Welfare.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 7-valent pneumococcal-OMPC conjugate vaccine TARGET | 7-valent pneumococcal-OMPC conjugate vaccine | Finnish Institute for Health and Welfare | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 7-valent pneumococcal-OMPC conjugate vaccine CI watch — RSS
- 7-valent pneumococcal-OMPC conjugate vaccine CI watch — Atom
- 7-valent pneumococcal-OMPC conjugate vaccine CI watch — JSON
- 7-valent pneumococcal-OMPC conjugate vaccine alone — RSS
Cite this brief
Drug Landscape (2026). 7-valent pneumococcal-OMPC conjugate vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/7-valent-pneumococcal-ompc-conjugate-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab